These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 559310

  • 1. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M.
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract] [Full Text] [Related]

  • 2. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 3. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR, Emerich DF, el-Etri MM, Shipley MT, Zanol MD, Cahill DW, Norman AB.
    Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L.
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [Abstract] [Full Text] [Related]

  • 5. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
    Castelló ME, Bolioli B, Dajas F.
    Pharmacol Biochem Behav; 1992 Mar; 41(3):547-50. PubMed ID: 1584833
    [Abstract] [Full Text] [Related]

  • 6. Effect of drugs on metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L.
    Br J Pharmacol; 1975 Mar; 53(3):460P. PubMed ID: 1169083
    [No Abstract] [Full Text] [Related]

  • 7. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M, Mataga N, Takashima M, Nishikawa T.
    Psychopharmacology (Berl); 1981 May; 74(4):316-20. PubMed ID: 6794073
    [Abstract] [Full Text] [Related]

  • 9. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ, Korf J.
    Psychopharmacology (Berl); 1986 May; 90(1):54-7. PubMed ID: 3094062
    [Abstract] [Full Text] [Related]

  • 10. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
    Millington WR, Wurtman RJ.
    Eur J Pharmacol; 1982 Jun 04; 80(4):431-4. PubMed ID: 7106193
    [Abstract] [Full Text] [Related]

  • 11. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A, Parenti M, Galli CL, Bugatti A, Cattabeni F, Di Giulio AM, Racagni G.
    Life Sci; 1978 Oct 30; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract] [Full Text] [Related]

  • 12. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F, Achilli G, Perego C, Algeri S.
    Neurosci Lett; 1981 Nov 18; 27(1):61-7. PubMed ID: 7329624
    [Abstract] [Full Text] [Related]

  • 13. Analysis of extracellular DOPAC, HVA and 5-HIAA in rat striatum in vivo by differential pulse voltammetry: effect of phencyclidine, haloperidol and their coadministration.
    Crespi F, Keane PE.
    Pharmacol Res Commun; 1987 Sep 18; 19(9):639-49. PubMed ID: 2448834
    [Abstract] [Full Text] [Related]

  • 14. Metoclopramide induces catalepsy and increases striatal homovanillic acid content in mice.
    Ahtee L, Buncombe G.
    Acta Pharmacol Toxicol (Copenh); 1974 Nov 18; 35(5):429-32. PubMed ID: 4479719
    [No Abstract] [Full Text] [Related]

  • 15. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR, Kim C.
    Res Commun Chem Pathol Pharmacol; 1978 Jul 18; 21(1):37-44. PubMed ID: 567367
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin.
    Olgiati VR, Algeri S, Stramentinoli G.
    Pharmacol Res Commun; 1987 Mar 18; 19(3):231-40. PubMed ID: 3602044
    [Abstract] [Full Text] [Related]

  • 17. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P, Bruinvels J, van Valkenburg CF.
    J Pharm Pharmacol; 1978 Sep 18; 30(9):583-5. PubMed ID: 29101
    [No Abstract] [Full Text] [Related]

  • 18. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
    Kaneko M, Sato K, Horikoshi R, Yaginuma M, Yaginuma N, Shiragata M, Kumashiro H.
    Prostaglandins Leukot Essent Fatty Acids; 1992 May 18; 46(1):53-7. PubMed ID: 1378633
    [Abstract] [Full Text] [Related]

  • 19. Effects of piracetam on the central dopaminergic transmission.
    Rägo LK, Allikmets LH, Zarkovsky AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec 18; 318(1):36-7. PubMed ID: 6276786
    [Abstract] [Full Text] [Related]

  • 20. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P, Bruinvels J, van Valkenburg CF.
    Life Sci; 1978 Aug 14; 23(6):611-5. PubMed ID: 692284
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.